▲ +62.23% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for OrganiGram in the last 3 months. The average price target is $2.64, with a high forecast of $4.00 and a low forecast of $1.72. The average price target represents a 62.23% upside from the last price of $1.63.
The current consensus among 12 polled investment analysts is to hold stock in OrganiGram. This rating has held steady since January 2020, when it changed from a Buy consensus rating.
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.